Recombinant activated factor VII in approved indications: Update on safety
Gespeichert in:
| Veröffentlicht in: | Haemophilia : the official journal of the World Federation of Hemophilia 2018-07, Vol.24 (4), p.e275-e277 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e277 |
|---|---|
| container_issue | 4 |
| container_start_page | e275 |
| container_title | Haemophilia : the official journal of the World Federation of Hemophilia |
| container_volume | 24 |
| creator | Neufeld, E. J. Négrier, C. Benchikh el Fegoun, S. Cooper, D. L. Rojas‐Rios, A. Seremetis, S. |
| description | |
| doi_str_mv | 10.1111/hae.13547 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2070244921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2070244921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3887-ba36d6ed8451cb5a752b866ce7a3c88e2553cf1cc9fa7bfab579c7900beb4863</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlYXvoAMuNHF2Fwml3FXSrWVgiDVbUgyGUyZS53MVPr2pk51IXg25-fw8XH4AbhE8A6FGb8re4cITfgRGCLCaIwpYsf7TFEsMGIDcOb9GkJEMGSnYEAghAnDdAieXqypS-0qVbWRMq3bqtZmUR5i3URvi0XkqkhtNk29DWdXZc6o1tWVv49eN1lgo7qKvMptuzsHJ7kqvL047BFYPcxW03m8fH5cTCfL2BAheKwVYRmzmUgoMpoqTrEWjBnLFTFCWEwpMTkyJs0V17nSlKeGpxBqqxPByAjc9Nrw00dnfStL540tClXZuvMSQw5xkqQYBfT6D7quu6YKzwUqxQkRJN0Lb3vKNLX3jc3lpnGlanYSQbnvV4Z-5Xe_gb06GDtd2uyX_Ck0AOMe-HSF3f1vkvPJrFd-AXwvg0I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2092438396</pqid></control><display><type>article</type><title>Recombinant activated factor VII in approved indications: Update on safety</title><source>Wiley-Blackwell Journals</source><creator>Neufeld, E. J. ; Négrier, C. ; Benchikh el Fegoun, S. ; Cooper, D. L. ; Rojas‐Rios, A. ; Seremetis, S.</creator><creatorcontrib>Neufeld, E. J. ; Négrier, C. ; Benchikh el Fegoun, S. ; Cooper, D. L. ; Rojas‐Rios, A. ; Seremetis, S.</creatorcontrib><identifier>ISSN: 1351-8216</identifier><identifier>EISSN: 1365-2516</identifier><identifier>DOI: 10.1111/hae.13547</identifier><identifier>PMID: 30004625</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Coagulation factors</subject><ispartof>Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.e275-e277</ispartof><rights>2018 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3887-ba36d6ed8451cb5a752b866ce7a3c88e2553cf1cc9fa7bfab579c7900beb4863</citedby><cites>FETCH-LOGICAL-c3887-ba36d6ed8451cb5a752b866ce7a3c88e2553cf1cc9fa7bfab579c7900beb4863</cites><orcidid>0000-0002-6769-097X ; 0000-0002-4499-1526</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhae.13547$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhae.13547$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30004625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neufeld, E. J.</creatorcontrib><creatorcontrib>Négrier, C.</creatorcontrib><creatorcontrib>Benchikh el Fegoun, S.</creatorcontrib><creatorcontrib>Cooper, D. L.</creatorcontrib><creatorcontrib>Rojas‐Rios, A.</creatorcontrib><creatorcontrib>Seremetis, S.</creatorcontrib><title>Recombinant activated factor VII in approved indications: Update on safety</title><title>Haemophilia : the official journal of the World Federation of Hemophilia</title><addtitle>Haemophilia</addtitle><subject>Coagulation factors</subject><issn>1351-8216</issn><issn>1365-2516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kMtKAzEUhoMotlYXvoAMuNHF2Fwml3FXSrWVgiDVbUgyGUyZS53MVPr2pk51IXg25-fw8XH4AbhE8A6FGb8re4cITfgRGCLCaIwpYsf7TFEsMGIDcOb9GkJEMGSnYEAghAnDdAieXqypS-0qVbWRMq3bqtZmUR5i3URvi0XkqkhtNk29DWdXZc6o1tWVv49eN1lgo7qKvMptuzsHJ7kqvL047BFYPcxW03m8fH5cTCfL2BAheKwVYRmzmUgoMpoqTrEWjBnLFTFCWEwpMTkyJs0V17nSlKeGpxBqqxPByAjc9Nrw00dnfStL540tClXZuvMSQw5xkqQYBfT6D7quu6YKzwUqxQkRJN0Lb3vKNLX3jc3lpnGlanYSQbnvV4Z-5Xe_gb06GDtd2uyX_Ck0AOMe-HSF3f1vkvPJrFd-AXwvg0I</recordid><startdate>201807</startdate><enddate>201807</enddate><creator>Neufeld, E. J.</creator><creator>Négrier, C.</creator><creator>Benchikh el Fegoun, S.</creator><creator>Cooper, D. L.</creator><creator>Rojas‐Rios, A.</creator><creator>Seremetis, S.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6769-097X</orcidid><orcidid>https://orcid.org/0000-0002-4499-1526</orcidid></search><sort><creationdate>201807</creationdate><title>Recombinant activated factor VII in approved indications: Update on safety</title><author>Neufeld, E. J. ; Négrier, C. ; Benchikh el Fegoun, S. ; Cooper, D. L. ; Rojas‐Rios, A. ; Seremetis, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3887-ba36d6ed8451cb5a752b866ce7a3c88e2553cf1cc9fa7bfab579c7900beb4863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Coagulation factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Neufeld, E. J.</creatorcontrib><creatorcontrib>Négrier, C.</creatorcontrib><creatorcontrib>Benchikh el Fegoun, S.</creatorcontrib><creatorcontrib>Cooper, D. L.</creatorcontrib><creatorcontrib>Rojas‐Rios, A.</creatorcontrib><creatorcontrib>Seremetis, S.</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neufeld, E. J.</au><au>Négrier, C.</au><au>Benchikh el Fegoun, S.</au><au>Cooper, D. L.</au><au>Rojas‐Rios, A.</au><au>Seremetis, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recombinant activated factor VII in approved indications: Update on safety</atitle><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle><addtitle>Haemophilia</addtitle><date>2018-07</date><risdate>2018</risdate><volume>24</volume><issue>4</issue><spage>e275</spage><epage>e277</epage><pages>e275-e277</pages><issn>1351-8216</issn><eissn>1365-2516</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30004625</pmid><doi>10.1111/hae.13547</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6769-097X</orcidid><orcidid>https://orcid.org/0000-0002-4499-1526</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1351-8216 |
| ispartof | Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.e275-e277 |
| issn | 1351-8216 1365-2516 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2070244921 |
| source | Wiley-Blackwell Journals |
| subjects | Coagulation factors |
| title | Recombinant activated factor VII in approved indications: Update on safety |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T17%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recombinant%20activated%20factor%20VII%20in%20approved%20indications:%20Update%20on%20safety&rft.jtitle=Haemophilia%20:%20the%20official%20journal%20of%20the%20World%20Federation%20of%20Hemophilia&rft.au=Neufeld,%20E.%20J.&rft.date=2018-07&rft.volume=24&rft.issue=4&rft.spage=e275&rft.epage=e277&rft.pages=e275-e277&rft.issn=1351-8216&rft.eissn=1365-2516&rft_id=info:doi/10.1111/hae.13547&rft_dat=%3Cproquest_cross%3E2070244921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2092438396&rft_id=info:pmid/30004625&rfr_iscdi=true |